WebNews
Please enter a web search for web results.
NewsWeb
Cutaneous Lupus Erythematosus Market Set for First Targeted Therapy in 70 Years as Approval Nears | Thelansis
8+ hour, 17+ min ago (87+ words) open PR. com Cutaneous Lupus Erythematosus Market Set for First Targeted Therapy in 70 Years as Approval Nears | Thelansis Press release from: THELANSIS KNOWLEDGE PARTNERS LLP Cutaneous Lupus Erythematosus (CLE) Market Outlook & Forecast 2026-2036 | Thelansis Permanent link to this press release: You…...
What arthritis really costs, and what modern medicine can now do about it
16+ hour, 35+ min ago (562+ words) The Times of India...
Stem cells banish severe autoimmune disease for 15 years
18+ hour, 9+ min ago (220+ words) Two people were the first to receive the therapy for a condition that damages the spinal cord and optic nerve. Two people were the first to receive the therapy for a condition that damages the spinal cord and optic nerve....
Kankakee hosts first Walk for Alopecia to raise awareness and funds
1+ day, 7+ hour ago (144+ words) Lauren Benedict is organizing Kankakee's first Walk for Alopecia on Saturday, September 26, from 9 a. m. to 11 a. m. at River Road Park. The walk aims to raise awareness and funds for alopecia areata, an autoimmune disease affecting nearly 7 million Americans. The condition causes hair…...
Q&A: Expanding Treatment to the Full Spectrum of Myasthenia Gravis
1+ day, 4+ hour ago (109+ words) James F. Howard Jr. , MD "This transcript has been edited for clarity. The responses that we did see in many of our patients were extremely gratifying, very similar to what we saw in ADAPT and ADAPT+that's one aspect. The other…...
House Appropriation Committee Approves Significant Increase in Federal Lupus Research and Education Funding
1+ week, 2+ day ago (33+ words) The U. S. House Appropriations Committee has voted to increase Fiscal Year 2027 funding for lupus programs at the Department of Health and Human Services, providing a total of $19 million for lupus. .....
Triple Therapy Improves Outcomes in High-Risk Lupus Nephritis
1+ day, 9+ hour ago (263+ words) Early initiation of triple therapy appears most appropriate for patients with lupus nephritis (LN) who harbor high-risk baseline features, whereas those at low or moderate risk achieve comparable outcomes with less intensive regimens, supporting a risk-adapted treatment paradigm. This research…...
Antengene Receives IND Approval for ATG-201 (CD19 " CD3 TCE) in Autoimmune Disease in China
1+ week, 2+ day ago (1134+ words) SHANGHAI and HONG KONG, June 9, 2026 /PRNewswire/ -- Antengene Corporation Limited" ('Antengene', SEHK: 6996. HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for autoimmune diseases, solid tumors and hematological malignancies indications, today…...
Re-Escalation of Anti-TNF Therapy Is Common in Older Adults With RA
3+ day, 8+ hour ago (422+ words) Re-escalation of anti-TNF therapy is common among older adults with RA and typically occurs within 6 months of prior de-escalation. Among adults aged 66 years and older with rheumatoid arthritis (RA), antitumor necrosis factor (TNF) de-escalation is frequently followed by re-escalation in…...
Where the 3 Major Lupus Nephritis Guidelines Agree and Differ
1+ week, 8+ hour ago (321+ words) Recent guidelines for lupus nephritis (LN) agree on early combination immunotherapy and glucocorticoid minimization but diverge in clinically meaningful ways, particularly in regimen selection, use of clinical profiling, and incorporation of emerging therapies, according to an article published in Nephrology…...